SPPI News and Press, Spectrum Pharmaceuticals Inc. From 04/28/20

ZENITH20 Phase 2 clinical trial amended to include new dosing regimens aimed at improving therapeutic index Management to host webcast and conference call today to review data and program strategy at 8:30 a.m. ET Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical compa...

Spectrum Pharmaceuticals (NasdaqGS: SPPI) a biopharmaceutical company focused on novel and targeted oncology therapies, today announced the appointment of Seth H.Z. Fischer to its Board of Directors. Mr. Fischer fills a vacancy left by Mr. Raymond Cohen, who retired from the Board effective A...

Management to host webcast and conference call to review data and program strategy at 8:30 a.m. ET on April 28, 2020 Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced the presentation of the results ...

New York City, NY:March 25, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of Castration Resistant Prostate Cancer Treatment Market in Global Industry: 2020 Research and New Innovations in Medical Devices Sector. The prime objective of the repo...

New York City, NY:March 25, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of Colorectal Cancer Market in Global Industry: 2020 Research and New Innovations in Medical Devices Sector. The prime objective of the report is to offer updates and in...

Conference call to discuss the data and strategy for the program originally scheduled for 8 a.m. ET on March 18, 2020 has been postponed Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that it had ...

Management to host webcast and conference call to review data and program strategy at 8 a.m. ET on March 18, 2020 Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced the acceptance for presentation of ...

In response to reporting fourth-quarter earnings, shares of  Spectrum Pharmaceuticals  (NASDAQ: SPPI) , a beaten-down clinical-stage biotech, rose 19% on Friday. Spectrum doesn't have any revenue yet, so the financial numbers in its "earnings" report aren't really all that meaningf...

Image source: The Motley Fool. Spectrum Pharmaceuticals Inc   (NASDAQ: SPPI) Q4 2019 Earnings Call Feb 27, 2020 , 4:30 p.m. ET Operator Continue reading

Spectrum Pharmaceuticals, Inc. (SPPI) Q4 2019 Results Earnings Conference Call February 27, 2020, 04:30 PM ET Company Participants Shiv Kapoor - Vice President, Strategic Planning & Investor Relations Joseph Turgeon - Chief Executive Officer Kurt Gustafson - Chief Financial O...